Table 1.
Potential benefits of evaluating WGS implementation in public health surveillance
| Potential benefits | |
|---|---|
| Inform the development of appropriate guidelines and policies around the use of pathogen whole genome sequencing in public health practice | |
| Contribute to the body of evidence available regarding development of pathogen whole genome sequencing capacity in a considered, informed way | |
| Identify needed investment, infrastructure and training to successfully incorporate microbial genomics into public health practice | |
| Provide clarity around the expected outcomes of incorporating pathogen whole genome sequencing in public health and evidence of whether these outcomes are being realised | |
| Identify unexpected outcomes of pathogen whole genome sequencing in public health (either positive or negative) and take appropriate action as necessary | |
| Ensure the public health benefits of whole genome sequencing technology are equitably distributed across the population | |
| Identify and reduce inefficiencies or redundancies in the system |